PM This week in cybersecurity: botnets, RCE flaws, AI-driven attacks, stealers, and more. Fast, no-fluff roundup.
Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results